SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-004385
Filing Date
2024-03-05
Accepted
2024-03-05 16:58:53
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5720
  Complete submission text file 0001209191-24-004385.txt   7194
Mailing Address C/O COLLAGENEX PHARMACEUTICALS, INC. 41 UNIVERSITY DRIVE NEWTOWN PA 18940
Business Address
Powell Andrew Kenneth William (Reporting) CIK: 0001304113 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 24721866

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)